UAG
TEVA icon

United Advisor Group’s Teva Pharmaceuticals TEVA Stock Holding History

United Advisor Group’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$530K Hold
17,600
– – 0.07% 273
2025
Q4 		$549K Buy
17,600
+1,500
+9% +$37K 0.07% 265
2025
Q3 		$325K Buy
+16,100
New +$283K 0.04% 343

Other funds holding TEVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $5.06B AUM 91.14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

United Advisor Group's TEVA Position: Q1 2026 in Review

United Advisor Group held its Teva Pharmaceuticals (TEVA) position steady in Q1 2026 at 17,600 shares worth $530K. The position accounts for 0.07% of the portfolio, ranked #273.

United Advisor Group first reported a position in TEVA in Q3 2025 and has held it in 3 quarters since. The position peaked at $549K in Q4 2025. 650 funds tracked by Wall St. Rank hold TEVA as of Q1 2026.

  • United Advisor Group held 17,600 shares of Teva Pharmaceuticals worth $530K as of Q1 2026.
  • United Advisor Group left its Teva Pharmaceuticals share count unchanged in Q1 2026.
  • Teva Pharmaceuticals made up 0.07% of United Advisor Group's portfolio in Q1 2026, its #273 holding.
  • United Advisor Group first reported a position in Teva Pharmaceuticals in Q3 2025 and has held it in 3 quarters since.
  • United Advisor Group's Teva Pharmaceuticals position peaked at $549K in Q4 2025.
  • 650 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2026.

Based on United Advisor Group's 13F filing for Q1 2026, filed 17 Apr 2026.